Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Am J Med Retrieve available abstracts of 50 articles: HTML format

Single Articles

July 2025
1. AJMAL M, Javed B, Kubba S, Singh K, et al
   Contemporary Review of Myocardial Bridging for Internists.
   Am J Med. 2025;138:1068-1073.
   PubMed     Abstract available
   
   
   June 2025
2. JIANG Y, Zhang H, Zhang C, Geng Y, et al
   Impact of dual antiplatelet therapy duration on long-term outcomes following chronic total occlusion percutaneous coronary intervention.
   Am J Med. 2025 Jun 6:S0002-9343(25)00348-1. doi: 10.1016/j.amjmed.2025.
   PubMed     Abstract available
   
   
   May 2025
3. FROOM P, Lellouche J, Shimoni Z
   TROPONIN TESTS IN PATIENTS ADMITTED TO INTERNAL MEDICINE DEPARTMENTS WITHOUT AN ACUTE CORONARY SYNDROME- LESS IS MORE.
   Am J Med. 2025 May 20:S0002-9343(25)00305-5. doi: 10.1016/j.amjmed.2025.
   PubMed     Abstract available
   
   
   
4. OLA O, Knott JD, De Michieli L, Lobo R, et al
   Lack of Change in the Incidence of Unstable Angina after Transition to High-Sensitivity Cardiac Troponin T.
   Am J Med. 2025 May 18:S0002-9343(25)00304-3. doi: 10.1016/j.amjmed.2025.
   PubMed     Abstract available
   
   
   
5. KU L, Yan Q, Deng W, Ma X, et al
   Right Coronary Artery Ulcerated Atheromatous Plaque.
   Am J Med. 2025 May 18:S0002-9343(25)00240-2. doi: 10.1016/j.amjmed.2025.
   PubMed    
   
   
   
6. TODUA I, Salem DN
   Cardioesophageal Reflex. Should It Trigger Clinician's Response?
   Am J Med. 2025;138:778-781.
   PubMed     Abstract available
   
   
   April 2025
7. POLLMANN DL, Knott JD, Carvalho PEP, Apple FS, et al
   Cardiac biomarkers for the prediction, discrimination, and risk-stratification of type 2 myocardial infarction: a critical appraisal.
   Am J Med. 2025 Apr 26:S0002-9343(25)00239-6. doi: 10.1016/j.amjmed.2025.
   PubMed     Abstract available
   
   
   
8. GELFMAN DM
   Colchicine in Coronary Artery Disease. When to Use?
   Am J Med. 2025 Apr 15:S0002-9343(25)00230-X. doi: 10.1016/j.amjmed.2025.
   PubMed    
   
   
   March 2025
9. RULI TM JR, Szarvas D, D'Amico A, Leesar M, et al
   A Case of Thyrotoxicosis-Induced Prinzmetal Angina Mimicking Acute ST-Elevation Myocardial Infarction.
   Am J Med. 2025 Mar 28:S0002-9343(25)00199-8. doi: 10.1016/j.amjmed.2025.
   PubMed    
   
   
   
10. MASINI G, Barsacchi M, Chiusolo S, Alberti M, et al
    Iron Deficiency in Acute Coronary Syndromes - Clinical Correlates and Outcomes.
    Am J Med. 2025 Mar 20:S0002-9343(25)00154-8. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available
    
    
    
11. LI L, A G, Guo Y, Liu H, et al
    Early beta-Blocker Use and Clinical Outcomes in Acute Myocardial Injury: A Retrospective Cohort Study.
    Am J Med. 2025 Mar 6:S0002-9343(25)00140-8. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available
    
    
    February 2025
12. JIN IT, Lee Y, Choi EY, Lee SH, et al
    Aspirin and clinical outcomes in individuals with incidentally diagnosed coronary artery stenosis.
    Am J Med. 2025 Feb 17:S0002-9343(25)00094-4. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available
    
    
    
13. LI X, Huo Y, Diao X, Liu Y, et al
    Prevalence and clinical significance of low QRS voltages in patients presenting for cardiovascular or related diseases.
    Am J Med. 2025 Feb 10:S0002-9343(25)00062-2. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available
    
    
    
14. KIM JE, Joo J, Kuku KO, Downie C, et al
    Prevalence, Disparities, and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in US Adults, 2011-2018.
    Am J Med. 2025 Feb 3:S0002-9343(25)00063-4. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available
    
    
    January 2025
15. LIPPI G, Sanchis-Gomar F, Lavie CJ
    The recent (2018-2022) US monthly mortality for acute myocardial infarction still peaks in December and January.
    Am J Med. 2025 Jan 18:S0002-9343(25)00035-X. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available
    
    
    
16. ALPERT JS
    Perioperative Cardiovascular Management for Patients Undergoing Noncardiac Surgery: Guideline Updated.
    Am J Med. 2025 Jan 16:S0002-9343(24)00832-5. doi: 10.1016/j.amjmed.2024.
    PubMed    
    
    
    December 2024
17. MOVAHED MR, Irannejad K, Venard E, Keating L, et al
    Women with breast implants have higher adjusted abnormal cardiac testing and coronary angiography but lower coronary intervention.
    Am J Med. 2024 Dec 31:S0002-9343(24)00845-3. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
18. SIEGEL J
    Aspirin guided by coronary artery calcium scoring for primary cardiovascular prevention in persons with subclinical coronary atherosclerosis.
    Am J Med. 2024 Dec 12:S0002-9343(24)00798-8. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
19. YANG H, Luo L, Huang Z, Song Y, et al
    Association Between Patient and System Delays and In-Hospital Mortality in Primary PCI for STEMI: Findings from a Large, Nationwide Inpatients Sample.
    Am J Med. 2024;137:1227-1235.
    PubMed     Abstract available
    
    
    November 2024
20. ABUGROUN A, Shah SJ, Fitzmaurice G, Hubbard C, et al
    The Association Between Accelerated Biological Aging and Cardiovascular Outcomes in Older Adults with Hypertension.
    Am J Med. 2024 Nov 12:S0002-9343(24)00702-2. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
21. JEHLE DVK, Sunesra R, Uddin H, Paul KK, et al
    Benefits of Tadalafil and Sildenafil on Mortality, Cardiovascular Disease, and Dementia.
    Am J Med. 2024 Nov 10:S0002-9343(24)00705-8. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
22. YAO Z, Gue Y, Lip GYH
    Comparison of Direct Oral Anticoagulants and Vitamin K Antagonists for Left Ventricular Thrombus: A Global Retrospective Study.
    Am J Med. 2024 Nov 8:S0002-9343(24)00703-4. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
23. DRAVES J, Tekiner H, Yale SH, Yale ES, et al
    Cardiovascular Physical Examination in Internal Medicine Residents: Pause for Concern.
    Am J Med. 2024;137:e213-e214.
    PubMed    
    
    
    October 2024
24. FATUROS A, Wong M, Ghasemiesfe A, Amsterdam EA, et al
    SOCIODEMOGRAPHIC DISPARITIES IN CORONARY ARTERY CALCIUM SCREENING.
    Am J Med. 2024 Oct 16:S0002-9343(24)00643-0. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
25. ABUHASIRA R, Burrack N, Turjeman A, Patt YS, et al
    Comparative Analysis of First-Line Antihypertensive Treatment Classes.
    Am J Med. 2024 Oct 16:S0002-9343(24)00645-4. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
26. DE ALENCAR JN
    Data Concerns in Myocardial Infarction with Right Bundle Branch Block Study: A Closer Look at Methodological Issues.
    Am J Med. 2024;137:e197.
    PubMed    
    
    
    
27. GUIMARAES PO, Lopes RD, Wojdyla DM, Alexander JH, et al
    Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial.
    Am J Med. 2024;137:958-965.
    PubMed     Abstract available
    
    
    September 2024
28. TSAI MH, Chen YY, Liou HH, Wang JT, et al
    Febuxostat leads to better cardiovascular outcomes compared to allopurinol in patients with advanced chronic kidney disease: A Population-based Cohort Study.
    Am J Med. 2024 Sep 26:S0002-9343(24)00622-3. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
29. KIM YJ, Malhi J, Trost J, Leucker T, et al
    A Case-Based Approach to the Management of Patients with Chronic Coronary Disease: Updates from the 2023 AHA/ACC Guidelines.
    Am J Med. 2024 Sep 14:S0002-9343(24)00576-X. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
30. JORDA A, Pecho T, Horvath LC, Nishani E, et al
    Association of electrocardiogram findings with clinical outcomes in patients with chronic coronary syndrome: an analysis of the ISCHEMIA trials.
    Am J Med. 2024 Sep 14:S0002-9343(24)00572-2. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    August 2024
31. MADIAS JE
    Blood pressure/Heart Rate-Derived Ratios, as Indices of Health and Cardiovascular Pathology.
    Am J Med. 2024 Aug 10:S0002-9343(24)00492-3. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
32. KIM J, Kang D, Park H, Park TK, et al
    Angiotensin receptor blockers versus angiotensin converting enzyme inhibitors in acute myocardial infarction without heart failure.
    Am J Med. 2024 Aug 3:S0002-9343(24)00477-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
33. PALATNIC L, Kim JA, Kim SY, Moras E, et al
    Human Papillomavirus as Non-Traditional Cardiovascular Risk Factors: Fact or Fiction? Part 2.
    Am J Med. 2024 Aug 3:S0002-9343(24)00481-9. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
34. LYAS C
    The Beneficial Effects of Fruits and Vegetables on Kidney Disease Progression and Cardiovascular Disease Risk.
    Am J Med. 2024 Aug 2:S0002-9343(24)00486-8. doi: 10.1016/j.amjmed.2024.
    PubMed    
    
    
    
35. GARCIA-VEGA D, Cinza-Sanjurjo S, Eiras S, Gonzalez-Juanatey JR, et al
    Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry.
    Am J Med. 2024;137:761-769.
    PubMed     Abstract available
    
    
    
36. HONG B, Bea S, You SC, Chang Y, et al
    Comparative Effectiveness and Safety of Ticagrelor and Clopidogrel in Patients With or Without Chronic Liver Disease: A Nationwide Cohort Study.
    Am J Med. 2024;137:742-750.
    PubMed     Abstract available
    
    
    
37. SHAH KS, Makaryus AN
    Navigating Diversity: Optimizing Data Collection for Cardiovascular Health.
    Am J Med. 2024 Aug 1:S0002-9343(24)00482-0. doi: 10.1016/j.amjmed.2024.
    PubMed    
    
    
    July 2024
38. EJIRI K, Mok Y, Ding N, Chang PP, et al
    Chest symptoms and long-term risk of incident cardiovascular disease.
    Am J Med. 2024 Jul 30:S0002-9343(24)00474-1. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
39. GORAYA N, Madias NE, Simoni J, Kahlon M, et al
    Kidney and Cardiovascular Protection Using Dietary Acid Reduction in Primary Hypertension: A Five-Year, Interventional, Randomized, Control Trial.
    Am J Med. 2024 Jul 8:S0002-9343(24)00357-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
40. ARSHAD F
    Breaking Barriers: Enhancing Statins Utilization for Cardiovascular Protection in MAFLD.
    Am J Med. 2024;137:e142.
    PubMed    
    
    
    June 2024
41. PALATNIC L, Kim JA, Kim SY, Moras E, et al
    Human Papillomavirus as Non-Traditional Cardiovascular Risk Factors: Fact or Fiction? Part 1.
    Am J Med. 2024 Jun 24:S0002-9343(24)00397-8. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    May 2024
42. LANG K, Chew C, De La Rosa M, Bertram AK, et al
    Performance of Cardiovascular Physical Exam Skills by Internal Medicine Residents.
    Am J Med. 2024 May 11:S0002-9343(24)00269-9. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
43. SMATI H, Sellke FW, Bourque JM, Qadeer YK, et al
    Coronary Microvascular Dysfunction: A Guide for Clinicians.
    Am J Med. 2024 May 7:S0002-9343(24)00282-1. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
44. KAWADA T
    Depression, Cardiovascular Disease, and Mortality.
    Am J Med. 2024;137:e96.
    PubMed    
    
    
    April 2024
45. SORENSEN NA, Fakhri Y, Gossling A, Neumann JT, et al
    Impact of quantitative ST-T analysis in patients with suspected myocardial infarction presenting with right bundle branch block.
    Am J Med. 2024 Apr 24:S0002-9343(24)00244-4. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
46. VELASQUEZ GARCIA HA, Wong S, Jeong D, Binka M, et al
    Risk of major adverse cardiovascular events after SARS-CoV-2 infection in British Columbia: a population-based study.
    Am J Med. 2024 Apr 24:S0002-9343(24)00237-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    March 2024
47. HOWICK V JF, Saric P, Elwazir M, Newman DB, et al
    A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19.
    Am J Med. 2024 Mar 26:S0002-9343(24)00162-1. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
48. ROOS A, Edgren G
    High-Sensitivity Cardiac Troponins in Patients with Chest Pain and Treatment With Oral Antineoplastic Agents Associated With Cardiovascular Toxicity.
    Am J Med. 2024 Mar 13:S0002-9343(24)00143-8. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    
49. FREUND O, Shetrit A, Bar-Shai A, Zornitzki L, et al
    Smoking and respiratory diseases in patients with coronary microvascular dysfunction.
    Am J Med. 2024 Mar 12:S0002-9343(24)00134-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    
    February 2024
50. HAMMOND MM, Cameron NA, Shah NS, Khan SS, et al
    An Age-Period-Cohort Analysis of Cardiovascular Disease Mortality in the United States from 1999 to 2018.
    Am J Med. 2024 Feb 22:S0002-9343(24)00108-6. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.